- Home
- TNXP vs TMQ Comparison
TNXP vs TMQ Comparison
Compare TNXP & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- TMQ
- Stock Information
- Founded
- TNXP 2007
- TMQ 2004
- Country
- TNXP United States
- TMQ Canada
- Employees
- TNXP N/A
- TMQ N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- TMQ Precious Metals
- Sector
- TNXP Health Care
- TMQ Basic Materials
- Exchange
- TNXP Nasdaq
- TMQ Nasdaq
- Market Cap
- TNXP 213.7M
- TMQ 249.6M
- IPO Year
- TNXP N/A
- TMQ N/A
- Fundamental
- Price
- TNXP $18.12
- TMQ $4.00
- Analyst Decision
- TNXP Buy
- TMQ
- Analyst Count
- TNXP 1
- TMQ 0
- Target Price
- TNXP $70.00
- TMQ N/A
- AVG Volume (30 Days)
- TNXP 734.4K
- TMQ 22.7M
- Earning Date
- TNXP 11-07-2025
- TMQ 09-30-2025
- Dividend Yield
- TNXP N/A
- TMQ N/A
- EPS Growth
- TNXP N/A
- TMQ N/A
- EPS
- TNXP N/A
- TMQ N/A
- Revenue
- TNXP $9,831,000.00
- TMQ N/A
- Revenue This Year
- TNXP $14.79
- TMQ N/A
- Revenue Next Year
- TNXP $933.49
- TMQ N/A
- P/E Ratio
- TNXP N/A
- TMQ N/A
- Revenue Growth
- TNXP N/A
- TMQ N/A
- 52 Week Low
- TNXP $6.76
- TMQ $0.55
- 52 Week High
- TNXP $130.00
- TMQ $11.29
- Technical
- Relative Strength Index (RSI)
- TNXP 34.78
- TMQ 44.58
- Support Level
- TNXP $18.53
- TMQ $3.79
- Resistance Level
- TNXP $18.96
- TMQ $4.97
- Average True Range (ATR)
- TNXP 1.05
- TMQ 0.54
- MACD
- TNXP 0.39
- TMQ -0.37
- Stochastic Oscillator
- TNXP 24.31
- TMQ 6.03
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.